1-3 of 3
Sonali Joyce
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met

Free
Laura P. Stabile, Guoqing He, Vivian Wai Yan Lui, Sufi M. Thomas, Cassandra Henry, Christopher T. Gubish, Sonali Joyce, Kelly M. Quesnelle, Jill M. Siegfried, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (2): 380–392.
https://doi.org/10.1158/1078-0432.CCR-12-1555
Published: 16 January 2013
View articletitled, c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met
Open the PDF for c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met in another window
Includes: Supplementary data
Journal Articles

Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer

Free
Malabika Sen, Sonali Joyce, Mary Panahandeh, Changyou Li, Sufi M. Thomas, Jessica Maxwell, Lin Wang, William E. Gooding, Daniel E. Johnson, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (18): 4986–4996.
https://doi.org/10.1158/1078-0432.CCR-12-0792
Published: 16 September 2012
View articletitled, Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
Open the PDF for Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer in another window
Includes: Supplementary data
Journal Articles

Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab

Free
Neil E. Bhola, Sufi M. Thomas, Maria Freilino, Sonali Joyce, Anirban Sahu, Jessica Maxwell, Athanassios Argiris, Raja Seethala, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 4996–5004.
https://doi.org/10.1158/1078-0432.CCR-10-3406
Published: 31 July 2011
View articletitled, Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab
Open the PDF for Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab in another window
Includes: Supplementary data